Aave (AAVE) Price Prediction

Deep Dive

1. Broad market and price trend (Bearish Impact)

Overview: On November 11, AAVE was down 6.27% over seven days and 26.58% over 30 days. It traded below its 7 day and 30 day moving averages, while the wider crypto market’s Fear and Greed reading was 26, in “Fear” territory. These signals point to weak near term momentum, though AAVE remained above its 200 day simple moving average of $109.50.

What this means: If market risk appetite stays low, buyers may remain cautious and AAVE could face further selling. Holding above the 200 day average could help limit downside, but does not confirm a reversal. CMC market data

2. Native Bitcoin collateral on V4 (Mixed Impact)

Overview: Aave’s preliminary governance vote for native Bitcoin collateral passed on November 9. The proposal still needs final approval; a late 2026 launch is a target, not a confirmed date. Initial borrowing capacity is proposed at about $21 million, with rollout limits and liquidation risks still under discussion. CryptoSlate

What this means: If approved and used, the feature could draw more collateral and lending activity to Aave, supporting demand for the ecosystem. Delays, low uptake, or liquidation problems could weaken that benefit.

3. Proposed collateral restrictions (Mixed Impact)

Overview: On November 11, LlamaRisk proposed narrowing Aave V3 Core collateral, affecting roughly $1.33 billion in assets and $1.03 billion in associated debt as of November 9. The plan is not approved; freezes or collateral changes would require further action. The Defiant

What this means: Tighter limits could reduce risky exposures over time, but abrupt borrower migration or lower liquidity could unsettle users and weigh on sentiment.

Conclusion

Near term, weak market conditions and technical momentum are headwinds; later, Bitcoin lending could support the outlook if approved and adopted. For holders and traders, expect volatility and distinguish announced proposals from live changes.

Will AAVE’s Bitcoin collateral plan receive final approval, and will affected V3 exposures decline in an orderly way?